Daxor Corporation (DXR)

Develops and markets biotechnology instrumentation for blood volume analysis.

DXR Stock Quote

Company Report

Daxor Corporation, based in Oak Ridge, Tennessee, is a leading medical device company specializing in blood volume measurement technology. At the heart of its offerings is the BVA-100 Blood Volume Analyzer, a cutting-edge diagnostic tool that provides precise, objective quantification of blood volume status and composition. This innovative technology helps healthcare professionals assess and manage patients' blood volume in various medical and surgical settings, ensuring tailored treatment plans aligned with individual patient needs.

Originally known as Idant Corporation, Daxor Corporation underwent a name change in May 1973 to reflect its focus on advancing medical diagnostics through innovative solutions. Since its incorporation in 1971, the company has been dedicated to enhancing healthcare outcomes through accurate blood volume testing. By providing clinicians with reliable data compared to patient-specific norms, Daxor Corporation supports informed clinical decisions and improves patient care across diverse healthcare environments.

Daxor Corporation continues to drive innovation in blood volume measurement, leveraging decades of expertise and ongoing research to expand its technology's applications. With a commitment to advancing medical diagnostics, the company remains at the forefront of delivering reliable solutions that empower healthcare providers worldwide.

DXR EPS Chart

DXR Revenue Chart

Stock Research

UPST RNA FUSB CAAS BGXX NISN FELE

DXR Chart

View interactive chart for DXR

DXR Profile

DXR News

Analyst Ratings